Abstract
The rise of medical care expenditure over the last few decades has made the economic evaluation of medical services increasingly important. However, economic appraisal of specific medical therapies is a complex issue, particularly with respect to the benefit side of the analysis. Previous studies often have ignored treatment benefits, restricting analysis to cost differentials between treatment alternatives or have focused exclusively on improvements in patients’ earnings capacity through reductions of morbidity or mortality. Both approaches are clearly unsatisfactory if (i) a new therapy constitutes significant therapeutic progress without reducing treatment costs, (ii) the major effect of a new therapy is to improve patients’ well-being, enjoyment of life, or life quality rather than to increase longevity or earnings capacity and (iii) the benefits of a new therapy accrue mainly to patients who are not part of the labor force, i.e. persons working in the household or retired people. In all these situations, economic evaluation requires assessment of the direct and immediate treatment benefits: the improvement in patients’ well-being (life quality).
The research presented here was in the first phase financed by Thomae AG, Biberach, in the second by the Swiss National Science Foundation (Project No. 3.927-0.85). It draws on earlier work of other people who have been engaged in this project at some point: dipl. psych. Rosemarie Deutschmann (Deutschmann & Co., Basel) designed the patient questionnaire and did the interviews, Dr. Thomas Keller provided the two physician scales used in Section 7. The authors would like to thank Peter Zweifel for helpful comments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bell, D.E., H. Raiffa, and A. Tversky, Decision Making: Descriptive Normative and Positive Interactions, Cambridge: Cambridge University Press, 1988.
Box, G.E.P. and D.R. Cox, “An analysis of transformations”, Journal of the Royal Statistical Society, series B, pp. 211–243, 1962.
Card, W.I., M. Rusinkiewicz, and C.I. Phillips, “Utility Estimation of a Set of States of Health”, Methods of Information in Medicine 16, pp. 168–175, 1977.
Cegla, U.H., “Atmungserkrankungen — chronische Bronchitis”, Fortschritte der Medizin 4, pp. 97–100, 1982.
Deutschmann, R., Psychosoziale und wirtschaftliche Auswirkungen der chronischen Bronchitis, Pilotstudie, Deutschmann & Co., Forschungskreis für Gesundheit und Gesellschaft, Basel, 1984.
Fehrlinz, R., “Erkrankungen der Atemwege: chronische Bronchitis”, in: Fehrlinz, R., Lungen- und Bronchialerkrankungen. Ein Lehrbuch der Pneumologie, Thieme, 1974.
Hanson, E., “Effects of chronic lung disease on life in general and on sexuality: perceptions of adult patients”, Heart and Lung 11, pp. 435–441, 1982.
Hausman, J.A., “Specification tests in Econometrics”, Econometrica 46, pp. 1251–1272, 1978.
Haveman, R. and L. Wolfe, “Disability Status as an Unobservable: Estimates from a Structural Model”, Discussion Paper No 775–85, University of Madison, Wisconsin, 1985.
Hooijmans, E.M. and W.P.M.M. Van de Ven, “A Multiple Indicator Multiple Causes Health Status Index”, in: Actes du Xe Coloque International d’Econometrie Appliqué, Lion, 1983.
Infratestforschung (ed.), Gesundheitsforschung — Chronische Bronchitis in der Bundesrepublik Deutschland, München, 1985.
Jöreskog, K.G. and S. Goldberger, “Estimation of a Model with Multiple Indicators and Multiple Causes of a Single Latent Variable”, Journal of the American Statistical Association 70, pp. 631–639, 1975.
Keller, T., Gesundheitszustandsmessung in der ökonomischen Therapieevaluation, Diss. Basel, 1987.
Lebovitz, M.D., “The Relationship of Socio-Environmental Factors to the Prevalence of Obstructive Lung Diseases and other Chronic Conditions”, Journal of Chronic Diseases 30, pp. 599–611, 1977.
Lee, F.L., “Health and wages: A simultaneous equation model with multiple discrete indicators”, Discussion paper 79–197, University of Minnesota, 1979.
Leu, R.E., “Economic Evaluation of New Drug Therapies in Terms of Improved Life Quality”, Social Science and Medicine 21, pp. 1153–1161, 1985.
Leu, R.E., T. Schaub, und R. Deutschmann, “Chronische Bronchitis: Lebensqualität der Betroffenen und volkswirtschaftliche Kosten”, Praxis und Klinik der Pneumologie 40, pp. 367–371, 1986.
Leu, R.E. und T. Schaub, “Gesundheit, Behinderung und Lebensqualität: der Patient hat das Wort”, Gesundheitsökonomische Beiträge, Baden-Baden: Nomos, 1990.
Maddala, G.S., Econometrics, Tokyo: McGraw-Hill, 1977.
McSweeney, A.J. and K.T. Labuhn, “Chronic Obstructive Pulmonary Disease”, in: Spilker, B. (ed), Quality of Life Assessments in Clinical Trials, Raven Press, 1990.
Morgan, A.D., D.F. Peck, D.R. Buchanan and G.J. McHardy, “Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis”, British Medical Journal 286, pp. 171–173, 1983.
Muthny, F., “Wege der Krankheitsverarbeitung und Verarbeitungserfolg im Vergleich verschiedener chronischer Erkrankungen”, in: Speidel, H. and A. Strauss (eds.), Zukunftsaufgaben der psychosomatischen Medizin, Berlin: Springer, 1989.
Von Neumann, J. and O. Morgenstern, Theory of Games and Economic Behavior, Third Edition, Princeton: Princeton University Press, 1953.
Richardson, J., “Cost-Utility Analysis: What Should be Measured — Utility, Value or Health Year Equivalents?”, Paper presented at the 2nd World Conference on Health Economics, Zürich, September 1990.
Robinson, P.M. and M.C. Ferrara, “The Estimation of a Model for an Unobservable with Exogenous Causes”, in: D.J. Aigner and A.S. Goldberger (eds.), Latent Variables in Socio-Economic Models, Amsterdam: North Holland, 1977.
Schoenberg, R., G. Arminger, and L. Edlefsen, Linear Covariance Structures Version 1.1, User Guide, RJS Software, Kensington, Maryland, 1987.
Schoenberg, R. and G. Arminger, Linear Covariance Structures Version 2.0, User Guide, RJS Software, Kensington, Maryland, 1989.
Torrance, G.W., “Social Preferences for Health Status: An Empirical Evaluation of Three Measurement Techniques”, Socio-Economic Planning Science 10, pp. 129–136, 1976.
Torrance, G.W., “Measurement of Health State Utilities for Economic Appraisal”, Journal of Health Economics 5, pp. 1–30, 1986.
Van de Ven, W.P.M.M. and J. van der Gaag, “Health as an Unobservable — A MIMIC-Model of the Demand for Health Care”, Journal of Health Economics 1, pp. 157–183, 1982.
Van de Ven, W.P.M.M. and E.M. Hooijmans, The MIMIC-Health Status Index — What it is and How to Use it, Leyden: Center for Research in Public Economics, 1982.
Van Vliet, R.C.J.A. and B.M.S. van Praag, “Health Status Estimation on the Basis of MIMIC Health Care Models”, Journal of Health Economics 6, pp. 27–42, 1987.
Wagstaff, A., “The demand for Health — Some new empirical evidence”, Journal of Health Economics 5, pp. 195–233, 1986.
Ware, J.E. Jr., et al., “Choosing Measures of Health Status for individuals in general populations”, American Journal of Public Health 71, pp. 620–625, 1981.
Wolfe, B. and J. Behrman, “Determinants of women’s health status and health care utilization in a developing country: A latent variable approach”, The Review of Economics and Statistics, pp. 696–703, 1984.
Zweifel, P., Ein ökonomisches Modell des Arztverhaltens, Berlin: Springer, 1982.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Leu, R.E., Gerfin, M., Spycher, S. (1992). The validity of the MIMIC health index — some empirical evidence. In: Zweifel, P., Frech, H.E. (eds) Health Economics Worldwide. Developments in Health Economics and Public Policy, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2392-1_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-2392-1_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5055-5
Online ISBN: 978-94-011-2392-1
eBook Packages: Springer Book Archive